Anti Cancer Drugs: The Real Impact of Price Cuts Revealed

Anti cancer drugs are under scrutiny as public health campaigners question the Centre’s recent price cuts.

Stroke-prevention drug: Safe New Class with Proven Benefits

Stroke-prevention drug approval in China marks a global first for Bayer, offering new hope in treatment.

Hepatitis B Approval: Proven Cure Strategy Gains Focus

Hepatitis B Approval highlights GSK’s innovative approach to treatment.

Anuh Pharma Tarapur Plant: Proven Boost for API Capacity

Anuh Pharma Tarapur Plant acquisition boosts API capacity significantly. Discover the details behind this strategic move.

How to Choose the Right Patent Lawyer for Your Intellectual Property Goals

Learn how to choose the right patent lawyer for your intellectual property goals with essential tips and considerations.

FDA Approval Pill: Worth a Proven $400M+ Opportunity

FDA approval pill could revolutionize treatment and is projected to generate over $400 million in revenue.

Cancer Drug Prices: Clear Path to 70% Savings Ahead

Cancer drug prices could see a significant drop of up to 70% due to government action.

Medexus Specialty Drug Launches: A Smart Move for Growth

Medexus specialty drug launches are gaining attention for their potential impact on the market.

Sudarshan Chemical’s acquisition is a Smart Move for Growth

Sudarshan Chemical acquisition marks a significant investment in Sudarshan Colorants, enhancing market presence and potential.

FDA Approval Bone Drug: Teva’s Proven New Treatment

FDA approval bone drug marks a significant advancement in treatment options.